March 18, 2024
Darr elected president of the Association of Cancer Center Administrators
UNC Lineberger’s Associate Director of Administration David Darr has been elected as president of the Association of Cancer Center Administrators.
March 18, 2024
UNC Lineberger’s Associate Director of Administration David Darr has been elected as president of the Association of Cancer Center Administrators.
March 13, 2024
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.
March 11, 2024
Catherine Cheng, CCRP, helped launch the first phase of the UNC Lineberger cellular therapy program’s research protocols.
March 4, 2024
The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype will help patients match to more effective first-line therapies.
March 1, 2024
UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.
February 27, 2024
Ronny Bell, PhD, MS, continues to serve his community and give back to the native population that he cares for deeply, personally and professionally.
February 26, 2024
Sarah Mills, PhD, led a study team that examined the effects of banning the sale of menthol cigarettes, finding that it could lead to a meaningful reduction in smoking rates.
February 26, 2024
Marissa Hall, PhD, and colleagues published study findings on pink ribbon marketing done by companies whose products have a direct link to breast cancer, such as alcohol.
February 26, 2024
Hong Jin (HJ) Kim, MD, has been appointed vice chair of academic affairs in the UNC School of Medicine’s Department of Surgery and associate physician-in-chief of the N.C. Basnight Cancer Hospital.
February 21, 2024
UNC Lineberger has been selected for the newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.